Vivimed Labs Limited (NSE:VIVIMEDLAB)
India · Delayed Price · Currency is INR 6.79
-0.32 (-4.50%)
Mar 9, 2026, 3:29 PM IST
Vivimed Labs Market Cap
Vivimed Labs has a market cap or net worth of 589.52 million as of March 9, 2026. Its market cap has decreased by -53.22% in one year.
Market Cap
589.52M
Enterprise Value
4.42B
Revenue
1.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
6.79
Market Cap Chart
Since August 17, 2005, Vivimed Labs's market cap has decreased from 1.04B to 589.52M, a decrease of -43.32%. That is a compound annual growth rate of -2.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 589.52M | -59.76% |
| Dec 31, 2025 | 1.47B | 61.37% |
| Dec 30, 2022 | 907.91M | -49.54% |
| Dec 31, 2021 | 1.80B | 20.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 11.59B |
| Beta Drugs | 11.08B |
| Sigachi Industries | 7.31B |
| Valiant Laboratories | 2.90B |
| Bafna Pharmaceuticals | 2.65B |
| Nectar Lifesciences | 2.27B |
| Brooks Laboratories | 1.80B |
| Alpa Laboratories | 1.34B |